About DNA Capital
DNA Capital is a private equity firm founded in 2013. It is primarily based in Sao Paulo, Brazil. In the last 12 months, it has participated in 1 funding round.
Overall DNA Capital portfolio has seen 2 acquisitions, namely Cured, Feegow Clinic. A lot of funds co-invest with DNA Capital, with names like Valor Capital Group sharing a substantial percentage of its portfolio.
DNA Capital has a team of 13 people, including 8 partners.
Key Metrics
DNA Capital's Portfolio
They have invested in a total of 11 companies. Their most recent investment was in Memed (Series C round) on May 21, 2026. Here is the most recent investment by DNA Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
May 21, 2026 | Series C | 4571 | ||
Nov 03, 2022 | Series C | 9103 | ||
Nov 01, 2022 | Seed | 1997 | ||
Mar 30, 2022 | Seed | 8893 |
Here is the portfolio snapshot of DNA Capital:
Investments by Year
The maximum number of investments were made in 2022
Team profile of DNA Capital
DNA Capital has a team of 13 members including 8 Partners and 1 Venture Partner located in Brazil and United States. DNA Capital's team does not sit on the board of any company as of now.Here is a list of top team members in DNA Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Brazil | - | ||
Partner | Sao Paulo | - | ||
Partner | Brazil | - | - | |
Partner | Sao Paulo | - | ||
Partner | Atlanta | - | ||
Partner | Brazil | - | ||
Partner | Sao Paulo | - | ||
Partner | - | - | ||
Venture Partner | - | - | ||
Associate | Sao Paulo | - | ||
Associate | Sao Paulo | - |
Co-investors of DNA Capital
Over the past 13 years, 24 investors have co-invested in DNA Capital's portfolio companies.
- Top Co-investors of DNA Capital: 24 investors entered a company along with DNA Capital. These include investors like Valor Capital Group (2 companies).
DNA Capital News
•
J&J Impact Ventures backs DNA Capital to expand healthcare access in BrazilImpactAlpha•May 13, 2026•DNA Capital, Johnson & Johnson, com.br
•
Medical education platform Sanar seeks over R$200 million in roundNeofeed•Mar 25, 2025•Editora Sanar, DNA Capital, Valor Capital Group, VOX Capital and 4 others
•
e2ip technologies Completes $120 Million Growth Funding RoundCNW•Apr 26, 2023•National Bank of Canada, DNA Capital, Invest Quebec, McRock Capital and 2 others
•
Health broker for SMEs, Piwi raises R$ 20 million and wants to grow 10 times in three yearsFusoes & Aquisicoes•Dec 01, 2022•Pidigital, DNA Capital, Scale Up Venture Capital, Endeavor
•
DNA Capital sees opportunities in healthcare industry lag in technologyFusoes & Aquisicoes•Oct 22, 2022•DNA Capital
•
Souto Correa and Mattos Filho in cross-border healthtech buyLatin Lawyer•Sep 05, 2022•DocPlanner, Feegow Clinic, DNA Capital
•
Kwely, Senegal-Based B2B Marketplace Raises $700,000 in Latest Series SeedKenyan Wall Street•Apr 28, 2022•Kenyan Wall Street, WIC Capital, LoftyInc Capital Management, Haske Ventures and 2 others
•
•
Nice Healthcare picks up $30m Series AVCJ•Mar 10, 2022•Nice Healthcare, DNA Capital, Waterline Ventures, Conductive Ventures and 2 others
•
DNA Capital, Temasek and Fit Participações Lead ~USD20m Round for Brazilian Healthtech MemedLAVCA•Nov 01, 2021•DNA Capital, Temasek, Fit Participações, MeMed and 2 others
